Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2010

May 5, 2010

30071_dirs_2010-05-05_9b297367-aaa5-45c5-8415-8917729aa298.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2010-05-03

Reporting Person: Darkin Donald (Sr. Vice President, Pat Inter)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-05-03 ResMed Common Stock M 7500 $40.68 Acquired 7500 Direct
2010-05-03 ResMed Common Stock S 7500 $68.2143 Disposed 0 Direct
2010-05-03 ResMed Common Stock M 12500 $43.42 Acquired 12500 Direct
2010-05-03 ResMed Common Stock S 12500 $68.0672 Disposed 0 Direct
2010-05-03 ResMed Common Stock M 2000 $42.05 Acquired 2000 Direct
2010-05-03 ResMed Common Stock S 2000 $68.1673 Disposed 0 Direct
2010-05-03 ResMed Common Stock M 2500 $43.35 Acquired 2500 Direct
2010-05-03 ResMed Common Stock S 2500 $68.1395 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-05-03 ResMed Common Stock Options $40.68 M 7500 Disposed 2016-09-01 ResMed Common Stock (7500) Direct
2010-05-03 ResMed Common Stock Options $43.42 M 12500 Disposed 2014-08-01 ResMed Common Stock (12500) Direct
2010-05-03 ResMed Common Stock Options $42.05 M 2000 Disposed 2014-11-07 ResMed Common Stock (2000) Direct
2010-05-03 ResMed Common Stock Options $43.35 M 2500 Disposed 2015-10-01 ResMed Common Stock (2500) Direct

Footnotes

F1: Represents first date options became exercisable.

F2: This transaction ws executed in multiple trades at prices ranging from $68.08 to $68.47. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F3: This transaction was executed in multiple trades at prices ranging from $68 to $68.15. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F4: This transaction was executed in multiple trades at prices ranging from $68.14 to $68.20. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F5: This transaction was executed in multiple trades at prices ranging from $68.09 to $68.19. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.